← Back to list
All Provider Bulletin 414: Changes in Exclusion of Designated 340B Drugs for MassHealth Fee-for-Service Coverage
Act
by Jul 1, 2026
Effective date
Jul 1, 2026
Identified
Jun 18, 2026
Summary
Effective July 1, 2026, MassHealth will no longer pay for 340B drugs dispensed through pharmacy point-of-sale systems in fee-for-service plans. Providers must use non-340B drug stock for MassHealth FFS, PCC Plan, and Primary Care ACO members to receive reimbursement.
Get alerts when payers change rules like this one
We check MassHealth and other payers every day and email you when a change matches your specialty and state.
Get MassHealth alertsPolicy Monitoring is free. No card required.
What to do
by Jul 1, 2026 · 4 steps
01Billing team must coordinate with pharmacy staff to ensure all MassHealth FFS, PCC Plan, and Primary Care ACO members receive non-340B drug stock only.
02Update pharmacy systems to flag these plan types and prevent 340B drug dispensing through point-of-sale adjudication.
03Verify MassHealth Drug List for any drugs completely excluded when purchased through 340B program.
04Claims for 340B drugs billed through pharmacy point-of-sale will be denied.
Original notice
All Provider Bulletin 414: Changes in Exclusion of Designated 340B Drugs for MassHealth Fee-for-Service Coverage
mass.gov · Always check the source before changing claims.